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A B S T R A C T
Objective: Preeclampsia is a syndrome that affects 5% of all pregnancies, producing substantial maternal
and prenatal morbidity and mortality. Several studies have reported that cytokine genes are associated
with the persistence of preeclampsia or the severity of the disease. The aim of this study is to investigate
the relationships between the polymorphisms of interleukin-1 alpha-889 (IL-1A) gene and preeclamp-
sia.
Method: Genomic DNA was extracted from the peripheral blood of 305 patients with preeclampsia and
325 normal controls from Sayyad Shirazi Hospital of Golestan University. Then subjected to SSP-PCR
ampliﬁcation. STATA software and the chi square test were used for statistic calculations.
Results: The frequencies of IL-1A -889 genotypes C/C, T/T and C/T in preeclampsia cases were 34.8%, 8.2%,
57% and in controls were 20.9%, 7.6% and 71.3% respectively. There was a signiﬁcant 1.5 fold excess
frequency in genotype C/C in cases (CI = 1.44–3.07, OR = 2.1, P = 0.0001). There was a signiﬁcant
difference in the frequencies of alleles or genotypes in IL-1A promoter regions between patients with
preeclampsia and the control group. Turkomans showed the highest frequency of the C allele and
Sistanies had the lowest frequency of the C allele in preeclampsia compared to control groups (CI = 1.5–
3.9, OR = 2.48, P = 0.0001).
Conclusion: Our ﬁndings suggest that the IL-1A-899C/C genotype and C allele are associated with
susceptibility to preeclampsia.
 2015 Elsevier Ireland Ltd. All rights reserved.
Contents lists available at ScienceDirect
European Journal of Obstetrics & Gynecology and
Reproductive Biology
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate /e jo g rbIntroduction
Preeclampsia (PE) is a placenta-dependent disease that causes
mother and fetus systemic disorders [1,2]. It is characterized by
endothelial dysfunction throughout the maternal circulation,
resulting in hypertension and proteinuria which typically occurs
after 20 week gestation to after delivery during the postpartum
period [3–6]. PE2 is a major cause of maternal and fetal mortality
and morbidity worldwide [4]. The prevalence of this disease is
5–7.5% in the USA and 4–4.5% in Iran [4,7]. Several studies on PE* Corresponding author. Tel.: +98 173 235 17 35; fax: +98 173 235 17 35.
E-mail address: shahbazimajid@yahoo.co.uk (M. Shahbazi).
1 These two authors have got equal right as a ﬁrst author.
2 Preeclampsia.
http://dx.doi.org/10.1016/j.ejogrb.2015.06.020
0301-2115/ 2015 Elsevier Ireland Ltd. All rights reserved.indicated that ethnic and genetic factors may contribute to the
increased risk of PE [1,8,9]. Also, the role of immune system
variations in the pathophysiology of preeclampsia has been
reported in many studies [10].
Cytokines are a major group of extracellular signal proteins that
regulate, proliferate and make cell-to-cell connections in the
immune system. Cytokine signals have an important role in the
different stages of health and diseases and increases in inﬂammatory
cytokines such as IL-1, IL-10, IL-6 and INF-gamma that are produced
in response to local hypoxia and ischemia of the placenta which
might trigger endothelial and result in preeclampsia [11–13]. There-
fore, the gene encoding pre-inﬂammatory cytokines participating in
the regulation of the immune response are good candidates for
further studying maternal genetic susceptibility to preeclampsia.
IL-1 is one of cytokines that plays a central role in the
inﬂammation and endothelial function. All family of these genes
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phic. These polymorphisms are in regulatory regions; they have
an important role in regulating the production proteins of IL-1,
and are associated with several diseases [14,15]. IL-1A is a
subtype of pre-inﬂammatory cytokines which induce the
expression of 40 several inﬂammatory factors [16]. Haggeri
et al. (2005) found an association between this position and
preeclampsia; but there are not more studies in the position of
IL-1A apparently [17].
In this study, the polymorphism in IL-1A gene was investigated
in preeclamptic women to elucidate the association between IL-1A
gene polymorphism (-889) and susceptibility to preeclampsia.
Materials and methods
In this study, the blood samples were collected from
305 preeclampsia women and 325 control women with no history
of preeclampsia who referred to Sayyad Shirazi Hospital of
Golestan University between March 2010 and May 2013. Women
with inﬂammatory, autoimmune and chronic diseases or infections
such as HBV were excluded. Controls were selected from among
healthy pregnant women who were admitted to the labor ward.
Preeclampsia was deﬁned as the development of hypertension of
above 140 and 90 mm Hg of systolic and diastolic pressure with
proteinuria of +1 or >300 mg in 24 h without renal diseases and
infection (according to the report of National High Blood Pressure
Education Program Working Group, 2000). Women with chronic
hypertension or HELLP syndrome (hemolysis, elevated liver
enzymes, and low platelet count) without preeclampsia were also
excluded from the study. Ethical approval for data collection and the
project was approved by the ethics committee of Golestan University
of Medical Sciences (Registration Number: 351599012254 and date
of issue: 2/16/2012).
DNA was extracted from the whole blood using a standard
phenol-chloroform extraction method and diluted to 50 ng/ml.
IL-1A gene polymorphism (-889C/T) was genotyped by speciﬁc
sequence primer polymerase chain reaction (SSP-PCR). Details of
primer sequences and fragment size for determining of IL-1A gene
polymorphism and human growth hormone (HGH) gene as an
internal control are provided in Table 1. The PCR (polymerase chain
reaction) ampliﬁcation was followed by a 15 ml reaction mixture
containing 1 ml of genomic DNA, 0/9 ml of 25 mm mgcl2 (Qiagen,
USA), 1/5 ml of each 10x buffer (Qiagen, USA), 1/5 ml of 10 mm
dNTP, 2/2 ml of sucrose 60%, 0/5 VL of each 10pm speciﬁc primer, 0/
5 ml of each 10pm HGH primers and 0/2 of taq polymerase (Qiagen,
USA). The cycling protocol was included in an initial denaturation
at 968C for 1 min, 10 cycles for 15 s at 96 8C, 50 s at 63 8C, 40 s at
72 8C (loop 1) and was followed by 20 cycles for 1 min at 96 8C, 50 s
at 58 8C, 40 s at 72 8C (loop 2). A total of 30 cycles was carried out,
with a ﬁnal extension at 72 8C for 5 min. The PCR products were
subjected to electrophoresis on 1/5% agarose gels and photo-
graphed under a UV trans-illuminator (2006 bio-red gel doc) after
staining with ethidium bromide. Allele frequencies were tested forTable 1
PCR primer sequences for IL-1A (-889).
Gene Annealing
temperature
Fragment
size (bp)
Primers
IL-1A 63 221 FW: 50-CTTTAATAATAGTAACCAGGCAACAT-30
FM: 50-CTTTAATAATAGTAACCAGGCAACAC-30
R: 50-AAGTAGCCCTCTACCAAGGA-30
HGH 64 429 HGH1: 50-GCC TTC CCA ACC ATT CCC TTA-30
HGH2:
50-TCA CGG ATT TCT GTT GTG TTT C-30hardy-Weinberg equilibrium using Chi-squared test and/or Fisher
exact test. These tests were used to compare the genotype
frequency between preeclamptic and control groups. SPSS
16 software (IBM, Armonk, NY, USA) was also applied, the level
of statistical signiﬁcance was deﬁned as P < 0.05, odds ratios (ORs)
were calculated on a 95% conﬁdence interval (CI).
Results
Using SSP-PCR, the fragments containing the positions where
the IL-1/_889 SNP occurred in 305 patients with preeclampsia and
325 control subjects were ampliﬁed. Statistical analysis showed a
signiﬁcant difference between preeclampsia and control groups in
terms of allelic and genotype frequency (Table 2) so that the C/C
genotype frequency was signiﬁcantly higher in the patients
(CI = 1.44–3.07, OR = 2.1, P = 0.0001). Also, the C allele frequency
was signiﬁcantly higher in the patients than control group
(CI = 1.04–1.66, OR = 1.32, P = 0.016), while T allele did not show
any signiﬁcant difference between the two groups. However the
present study demonstrated a signiﬁcant relationship between of
the IL-1A/-889 gene polymorphism and preeclampsia. Case and
control groups of this work were separated into three groups based
on reproductive age that included: <18, between 18 and 40 and
>40 years old. In terms of ethnicity, they were divided into four
subgroups of Persian, Turkoman, Sistani and others3 based on the
participant’s biography. Statistical observations are summarized
in Table 3.
Investigation in the mentioned age groups showed no statisti-
cally signiﬁcant differences between the case and control groups.
But, studying the ethnicity provided the following results:
Although genotyping of the following ethnic groups was slightly
different, these changes were not statistically signiﬁcant and
needed to be studied in a larger population. However, studies
demonstrated signiﬁcant allelic differences so that the C allele
signiﬁcantly increased in the sub-groups of Turkomans, Persians,
and Sistanies respectively. Turkomans showed the highest
frequency of the C allele and Sistanies had the lowest frequency
of the C allele in preeclampsia compared to control groups.
However, T allele was signiﬁcantly increased in the sub-groups of
Sistanies, Persians, and Turkomans respectively. The obtained
results are separately shown in Table 4.
Comments
In this study, the region of the IL1a gene position -889 was
analyzed using SSP-PCR and a T to C polymorphism was identiﬁed
in this position relative to preeclampsia. Highly signiﬁcant
correlation was found between homozygosity for the IL1a -
889*C allele and development of PE. Also, the investigation of sub-
ethnic groups in this study showed that Turkomans had the
highest percentage of the C allele and Sistani ethnicity had the
lowest percentage in PE compared with control groups. These data
suggested that the C allele might be as a susceptibility factor for
preeclampsia in Turkoman ethnicity and T allele can have a
protective role against PE in Sistani ethnicity.
Both genetics and inﬂammatory factors play a vital role in the
pathogenesis of preeclampsia [8,18]. Numerous studies have
demonstrated the role of inheritance in preeclampsia [19,20];
but, the way genetics and molecular mechanisms work in
preeclampsia is still unknown.
An aggressive inﬂammatory response may result in numerous
adverse reproductive outcomes including preeclampsia [21–24].
An abnormal genetic predisposition, for example, exaggerates
cytokine and may promote an inﬂammatory response which leads3 Other groups included Baluchistan and Afghanistan ethnicities.
Table 4
Frequencies of risk alleles (IL-1 -889C and T) in PEa patients and control ethnics sub-
groups.
Comparison PE Control OR 95%CI P value
C/Turkoman vs. C/Persian 82/188 46/167 1.58 1.02–2.46 0.0376
C/Persian vs. C/Sistani 188/97 167/135 1.56 1.10–2.21 0.0089
C/Turkoman vs. C/Sistani 82/97 46/135 2.48 1.55–3.97 0.0001
T/Sistani vs. T/Persian 57/112 107/133 0.63 0.41–0.96 0.031
T/Persian vs. T/Turkoman 112/42 133/28 0.56 0.31–0.99 0.0491
T/Sistani vs. T/Turkoman 57/42 107/28 0.35 0.19–0.65 0.0003
a PE, preeclampsia; OR, odds ratio; 95% CI, 95% conﬁdence interval.
Table 2
Allele and genotype frequencies of IL-1A/-889 in preeclampsia and healthy
pregnant controls.
IL1a
polymorphism
Controls
N = 325
PE
N = 305
OR 95% CI P valuea
Allele
C 368 (56.6%) 386 (63.2%) 1.32 1.04–1.66 0.016
T 282 (43.4%) 224 (36.7%) 1 – –
Genotype
C/C 68 (20.9%) 106 (34.8%) 2.1 1.44–3.07 0.0001
C/T 232 (71.3%) 174 (57%) 1 – –
T/T 25 (7.6%) 25 (8.2%) NS NS NS
OR = odds ratio; 95% CI = 95% conﬁdence interval.
a Fisher’s exact test.
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[25]. Instead, cytokine allele that was of functional relevance was
selected here, because it was assumed that genetic polymorphisms
that lead to increased pre-inﬂammatory cytokine production may
be associated with preeclampsia.
IL-1alpha is an important pre-inﬂammatory factor for begin-
ning of inﬂammatory diseases [16,26]. Based on the promoter role
of (-889) position of the IL-1a gene, the expected molecular
variation of this region leads to promoter activation, increases gene
transcription, and thus promotes the inﬂammatory response
[27]. Therefore, the present study revealed that polymorphism
of this gene may inﬂuence susceptibility factor for preeclampsia.
The only study which has been done on the IL-1alpha (-889)
gene polymorphism was by Haggeri et al. (2005) who investi-
gated several polymorphisms of cytokines and provided evi-
dence for the relationship between IL-1A genotype in -889
position in both white and black women with PE compared to the
control subjects so that the frequency of CC genotype was
associated with the increased risk of PE [17]. Also, Goodard et al.
investigated IL-1A polymorphism in three positions that were
different from those of the present study and demonstrated a
relationship between polymorphism in 4 and 6 intron positions
and PE along with a lack of relationship between polymorphism
in 5 exone position and PE [4].
Although the functional signiﬁcances of the IL-1A -889 and -
4845 polymorphisms lead to the variation of amino acids in IL-1A
protein and are associated with the increased risk of atopy [28], the
relationship between IL-1A gene polymorphism and preeclampsiaTable 3
Demographics in preeclamptic and healthy women.
Variables Healthy
women
n = 325 (%)
Preeclamptic
women
n = 305 (%)
P value
Classiﬁcation of preeclampsia
Mild preeclamptic – 218 (71.47) –
Sever preeclamptica – 87 (25.57)
Maternal age (year)
<18 10 (3.07) 7 (2.29) >0.05
18–40 314 (96.61) 294 (96.39)
>40 1 (0.30) 4 (1.31)
Ethnic
Persian 150 (46.1) 150 (49.1) <0.05b
Turkoman 37 (11.3) 62 (20.3)
Sistani 121 (37.2) 77 (25.2)
Other groups 17 (5.2) 16 (5.2)
a The presence of any one of these ﬁndings: Blood pressure 160/110 mmHg,
proteinuria > 5 g on a 24 h collection, liver and renal dysfunction, pulmonary
edema, fatal growth restriction.
b Based on chi square test; p < 0.05 was considered signiﬁcant.may indicate the functional role of C allele in sustaining the
immune response. Although this gene may be assumed as a strong
candidate which is associated with PE, it may vary in different
populations and is associated with multi-factorial diseases.
In conclusion, an association was founded between this
polymorphism and susceptibility to preeclampsia in the Iranian
population. However, future studies on different ethnic popula-
tions and on other polymorphic regions in cytokine genes would
provide a more accurate deﬁnition for the involvement of cytokine
genetic polymorphisms in the development of preeclampsia and
cytokine genotyping may prove to be an effective early pregnancy
preeclampsia risk-screening tool.
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